![Thomas Salzmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Salzmann
Geen lopende functies
Loopbaan van Thomas Salzmann
Eerdere bekende functies van Thomas Salzmann
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Puretech Health LLC
![]() Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | - | 30-07-2008 |
Satori Pharmaceuticals, Inc.
![]() Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satori Pharmaceuticals, Inc. developed therapeutics for alzheimer's disease. The firm's drug candidates selectively modulated gamma secretase, the enzyme generating the neurotoxic peptides that form amyloid beta plaques the signature of this debilitated disease. The company was founded by Mark A. Findeis and Dennis J. Selkoe in 2005 and was headquartered in Cambridge, MA. | Directeur/Bestuurslid | - | - |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Private Equity Investor | 1 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Puretech Health LLC
![]() Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Satori Pharmaceuticals, Inc.
![]() Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satori Pharmaceuticals, Inc. developed therapeutics for alzheimer's disease. The firm's drug candidates selectively modulated gamma secretase, the enzyme generating the neurotoxic peptides that form amyloid beta plaques the signature of this debilitated disease. The company was founded by Mark A. Findeis and Dennis J. Selkoe in 2005 and was headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Thomas Salzmann
- Ervaring